Preparation, Preservation, and Storage of Platelet Concentrates

Rossi's Principles of Transfusion Medicine: Fourth Edition

Volumn , Issue , 2009, Pages 187-198

  Vassallo, Ralph R ^a,b  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84991511081     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444303513.ch12     Document Type: Chapter

References (114)

1. Hoeltge GA, Shah A, Miller JP. An optimized strategy for choosing the number of platelet concentrates to pool. Arch Pathol Lab Med 1999;123:928-30.
2. Picker SM, Radojska SM, Gathof BS. Prospective comparison of high-dose plateletpheresis with the latest apheresis systems on the same donors. Transfusion 2006;46:1601-8.
3. US Department of Health and Human Services. The 2007 National Blood Collection and Utilization Survey Report. Washington, DC: DHHS, 2008.
4. Vassallo RR, Murphy S. A critical comparison of platelet preparation methods. Curr Opin Heme 2006;13:323-30.
5. Freireich EJ, Kliman A, Gaydos LA, et al. Response to repeated platelet transfusion from the same donor. Ann Intern Med 1963;59:277-87.
6. Murphy S, Gardner FH. Platelet preservation. Effect of storage temperature on maintenance of platelet viability-deleterious effect of refrigerated storage. N Engl J Med 1969;280:1094-8.
7. Mourad N. A simple method for obtaining platelet concentrates free of aggregates. Transfusion 1968;8:48.
8. Moroff G, Holme S, Heaton WA, et al. Effect of an 8-hour holding period on in vivo and in vitro properties of red cells and factor VIII content of plasma after collection in a red cell additive system. Transfusion 1990;30:828-32.
9. Code of federal regulations. Title 21 CFR §640.24(b). Washington, DC: US Government Printing Office, 2008 (revised annually).
10. Thibault L, Beauséjour A, deGrandmont MJ, et al. Characterization of blood components prepared from whole-blood donations after a 24-hour hold with the platelet-rich plasma method. Transfusion 2006;46:1292-9.
11. Moroff G, AuBuchon J, Heaton A, Holme S. Preparation of components from units of whole blood held for 24 hours at 20-24°C. Vox Sang 1994;67:48.
12. Price TH, ed. Standards for blood banks and transfusion services. 25th ed. Bethesda, MD: AABB, 2008.
13. Dzik WH, Cusack WF, Gacek MJ. Preparation of white cell-reduced platelet concentrates from whole blood during component preparation. Transfusion 1991;31:542-6.
14. Murphy S, Heaton WA, Rebulla P. Platelet production in the Old World-and the New. Transfusion 1996;36:751-4.
15. Guide to the preparation, use and quality assurance of blood components. 13th ed. Strasbourg: Council of Europe Publishing, 2007:114.
16. Heaton WAL, Rebulla P, Pappalettera M, Dzik WH. A comparative analysis of different methods for routine blood component preparation. Transfus Med Rev 1997;11:116-29.
17. Larsson S, Sandgren P, Sjodin A, et al. Automated preparation of platelet concentrates from pooled buffy coats: In vitro studies and experiences with the OrbiSac system. Transfusion 2005;45:743-51.
18. Pearson H, Davis KG, Wood EM, et al. Logistics of platelet concentrates. Vox Sang 2007;92:160-81.
19. Murphy S. Platelets from pooled buffy coats: An update. Transfusion 2005;45:634-9.
20. Santana JM, Dumont LJ. A flow cytometric method for detection and enumeration of low-level, residual red blood cells in platelets and mononuclear cell products. Transfusion 2006;46:966-72.
21. Lozano M, Cid J. The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility. Transfus Med Rev 2003;17:57-68.
22. Julmy F, Ammann RA, Wandall HH, Hoffmeister KM, Sorensen AL, et al. Galactosylation does not prevent the rapid clearance of longterm, 4 degrees C-stored platelets. Blood 2008;111:3249-56.
23. Matsunaga T, Tanaka I, Kobune M, et al. Ex vivo large-scale generation of human platelets from cord blood CD34+ cells. Stem Cells 2006;24:2877-87.
24. Food and Drug Administration. Reduction of the maximum platelet storage period to 5 days in an approved container. Rockville, MD: CBER Office of Communication, Training and Manufacturers Assistance, 1986.
25. Hay SN, Immel CC, McClannan LS, Brecher ME. The introduction of 7-day platelets: A university hospital experience. J Clin Apher 2007;22:283-6.
26. Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: Evidence for a fixed platelet requirement. Blood 1985;66:1105-9.
27. Holme S, Heaton A. In vitro platelet ageing at 22 degrees C is reduced compared to in vivo ageing at 37 degrees C. Br J Haematol 1995;91:212-18.
28. Lopez JA, DelConde I, Shrimpton CN. Receptors, rafts and microvesicles in thrombosis and inflammation. J Thromb Haemost 2005;3:1737-44.
29. Hoffmeister KM, Falet H, Toker A, et al. Mechanisms of cold- induced platelet actin assembly. J Biol Chem 2001;276:24751-9.
30. Hoffmeister KM, Felbinger TW, Falet H, et al. The clearance mechanism of chilled blood platelets. Cell 2003;112:1-20.
31. Oliver AE, Tablin S, Walker NJ, Crowe JH. The internal calcium concentration of human platelets increases during chilling. Biochim Biophy Acta 1999;1416:349-60.
32. White JG, Rao GHR. Microtubule coils versus the surface membrane cytoskeleton in maintenance and restoration of platelet discoid shape. Am J Pathol 1998;152:597-609.
33. Maurer-Spurej E, Pfeiler G, Maurer N, et al. Room temperature activates human blood platelets. Lab Invest 2001;81:581-92.
34. Murphy S, Rebulla P, Bertolini F, et al. In vitro assessment of the quality of stored platelet concentrates. Transfus Med Rev 1994;8:29-36.
35. Kaufman RM. Uncommon cold: Could 4°C storage improve platelet function? Transfusion 2005;45:1407-12.
36. Babic AM, Joseffson EC, Bergmeier W, et al. In vitro function and phagocytosis of galactosylated platelet concentrates after long-term refrigeration. Transfusion 2007;47:442-51.
37. Hoffmeister KM, Josefsson EC, Isaac NA, et al. Glycosylation restores survival of chilled blood platelets. Science 2003;301:1531-4.
38. Mansouri Taleghani B, et al. Effect of high-yield thrombocyta- pheresis on the quality of platelet products. Transfusion 2008;48:442-50.
39. Holme S, Sawyer S, Heaton A, Sweeney JD. Studies on platelets exposed to or stored at temperatures below 20°C or above 24°C. Transfusion 1997;37:5-11.
40. Kilkson H, Holme S, Murphy S. Platelet metabolism during storage of platelet concentrates at 22°C. Blood 1984;64:406-14.
41. Murphy S. Platelet storage for transfusion. Semin Hematol 1985;22:165-77.
42. Cesar J, DiMinno G, Alam I, et al. Plasma free fatty acid metabolism during storage of platelet concentrates for transfusion. Transfusion 1987;27:434-7.
43. Murphy S, Munoz S, Parry-Billings M, Newsholme E. Amino acid metabolism during platelet storage for transfusion. Br J Haematol 1992;81:585-90.
44. Gullikssen H. Defining the optimal storage conditions for the longterm storage of platelets. Transfus Med Rev 2003;17:209-15.
45. Farrugia A. Platelet concentrates for transfusion-metabolic and storage aspects. Platelets 1994;5:177-85.
46. Dumont LJ, Gulliksson H, van der Meer PF, et al. Interruption of agitation of platelet concentrates: A multicenter in vitro study by the BEST Collaborative on the effects of shipping platelets. Transfusion 2007;47:1666-73.
47. Solberg C, Holme S, Little C. Morphological changes associated with pH changes during storage of platelet concentrates in first-generation 3-day container. Vox Sang 1985;50:71-7.
48. Edenbrandt CM, Murphy S. Adenine and guanine nucleotide metabolism during platelet storage. Blood 1990;76:1884-92.
49. Cardigan R, Williamson LM. The quality of platelets after storage for 7 days. Transfus Med 2003;13:173-87.
50. Dumont LJ, AuBuchon JP, Gulliksson H, et al. In vitro pH effects on in vivo recovery and survival of platelets: An analysis by the BEST Collaborative. Transfusion 2006;46:1300-5.
51. Murphy S, Gardner FH. Platelet storage at 22°C: Role of gas transport across plastic containers in maintenance of viability. Blood 1975;46:209-18.
52. Wallvik J, Akerblom O. The platelet storage capability of different plastic containers. Vox Sang 1990;58:40-4.
53. Moroff G, Holme S. Concepts about current conditions for the preparation and storage of platelets. Transfus Med Rev 1991;5:48-59.
54. Snyder EL, Koerner TA Jr, Kakaiya R, et al. Effect of mode of agitation on storage of platelet concentrates in PL-732 containers for 5 days. Vox Sang 1983;44:300-4.
55. Wallvik J, Stenke L, Akerblom O. The effect of different agitation modes on platelet metabolism, thromboxane formation, and alpha-granular release during platelet storage. Transfusion 1990;30:639-43.
56. Mitchell SG, Hawker RJ, Turner VS, et al. Effect of agitation on the quality of platelet concentrates. Vox Sang 1994;67:160-5.
57. Hunter S, Nixon J, Murphy S. The effect of the interruption of agitation on platelet quality during storage for transfusion. Transfusion 2001;41:809-14.
58. Wagner SJ, Vassallo R, Skripchenko A, et al. The influence of simulated shipping conditions (24- or 30-hr interruption of agitation) on the in vitro properties of apheresis platelets during 7-day storage. Transfusion 2008;48:1072-80.
59. AuBuchon JP, Herschel L, Roger J, Murphy S. Preliminary validation of a new standard of efficacy for stored platelets. Transfusion 2004;44:36-41.
60. Dumont LJ, AuBuchon JP, Whitley P, et al. Seven-day storage of single-donor platelets: Recovery and survival in an autologous transfusion study. Transfusion 2002;42:847-54.
61. AuBuchon JP, Taylor H, Holme S, Nelson E. In vitro and in vivo evaluation of leukoreduced platelets stored for 7 days in CLX containers. Transfusion 2005;45:1356-61.
62. Seghatchian J, Krailadsiri P. The platelet storage lesion. Transfus Med Rev 1997;11:130-44.
63. Rinder HM, Snyder EL, Tracey JB, et al. Reversibility of severe metabolic stress in stored platelets after in vitro plasma rescue or in vivo transfusion: Restoration of secretory function and maintenance of platelet survival. Transfusion 2003;43:1230-7.
64. Murphy S. Radiolabeling of platelets to assess viability: A proposal for a standard. Transfusion 2004;44:131-3.
65. Murphy S. Utility of in vitro tests in predicting the in vivo viability of stored platelets (letter). Transfusion 2004;44:618-19.
66. Kunicki TJ, Tuccelli M, Becker GA, et al. A study of variables affecting the quality of platelets stored at "room temperature." Transfusion 1975;15:414-21.
67. Holme S, Moroff G, Murphy S. A multi-laboratory evaluation of in vitro platelet assays: The tests for extent of shape change and response to hypotonic shock. Transfusion 1998;38:31-40.
68. Seghatchian J. A new platelet storage lesion index based on paired samples, without and with EDTA and cell counting: Comparison of three types of leukoreduced preparations. Transfus Apher Sci 2006;35:283-92.
69. Bode AP. Platelet activation may explain the storage lesion in platelet concentrates. Blood Cells 1990;16:109-25.
70. DiMinno G, Silver MJ, Murphy S. Stored human platelets retain full aggregation potential in response to pairs of aggregating agents. Blood 1982;59:563-8.
71. Li J, Xia Y, Bertino AM, et al. The mechanism of apoptosis in human platelets during storage. Transfusion 2000;40:1320-9.
72. Leytin V, Freedman J. Platelet apoptosis in stored platelet concentrates and other models. Transfus Apher Sci 2003;28:285-95.
73. Gullikssen H. Additive solutions for the storage of platelets for transfusion. Transfus Med 2000;10:257-64.
74. Gullikssen H. Platelet additive solutions: Current status. Immunohematology 2007;23:14-19.
75. Andreu G, Vasse J, Hervè F, et al. Introduction of platelet additive solutions in transfusion practice. Advantages, disadvantages and benefit for patients. Transfus Clin Biol 2007;14:100-6.
76. Transfusion-related acute lung injury. Association Bulletin 06-07. Bethesda, MD: AABB, 2006.
77. Rock G, White J, Labow R. Storage of platelets in balanced salt solutions: A simple platelet storage solution. Transfusion 1991;31:21-5.
78. Adams GA, Swenson SD, Rock G. Survival and recovery of human platelets stored for five days in a non-plasma medium. Blood 1986;67:672-5.
79. Murphy S, Kagen L, Holme S, et al. Platelet storage in synthetic media lacking glucose and bicarbonate. Transfusion 1991;31:16-20.
80. Murphy S. The efficacy of synthetic media in the storage of human platelets for transfusion. Transfus Med Rev 1999;13:153-63.
81. Sweeney J, Kouttab N, Holme S, et al. Storage of platelet-rich plasma-derived platelet concentrate pools in plasma and additive solution. Transfusion 2006;46:835-40.
82. Ringwald J, Zimmermann R, Eckstein R. The new generation of platelet additive solution for storage at 22°C: development and current experience. Transfus Med Rev 2006;20:158-64.
83. Bode AP, Holme S, Heaton WA, Swanson MS. Extended storage of platelets in an artificial medium with the platelet activation inhibitors prostaglandin E1 and theophylline. Vox Sang 1991;60:105-12.
84. De Wildt-Eggen J, Gullikssen H. In vivo and in vitro comparison of platelets stored in either synthetic media or plasma. Vox Sang 2003;84:256-64.
85. Van der Meer PF, Pietersz RNI. Gamma irradiation does not affect 7-day storage of platelet concentrates. Vox Sang 2005;89:97-9.
86. Sweeney JD, Holme S, Moroff G. Storage of apheresis platelets after gamma irradiation. Transfusion 1994;34:779-83.
87. Read EJ, Kodis C, Carter CS, Leitman SF. Viability of platelets following storage in the irradiated state. A pair-controlled study. Transfusion 1988;28:446-50.
88. Heal JM, Blumberg N. Optimizing platelet transfusion therapy. Blood Rev 2004;18:149-65.
89. Buck SA, Kickler TS, McGuire M, et al. The utility of platelet washing using an automated procedure for severe platelet allergic reactions. Transfusion 1987;27:391-3.
90. Kalmin ND, Brown DJ. Platelet washing with a blood cell processor. Transfusion 1982;22:125-7.
91. Vo TD, Cowles J, Heal JM, Blumberg N. Platelet washing to prevent recurrent febrile reactions to leukocyte-reduced transfusions. Transfus Med 2001;11:45-7.
92. Pineda AA, Zylstra VW, Clare DE, et al. Viability and functional integrity of washed platelets. Transfusion 1989;29:524-7.
93. Sloand EM, Fox SM, Banks SM, Klein HG. Preparation of IgA-deficient platelets. Transfusion 1990;30:322-6.
94. Removing plasma from platelets (volume reduction). In: Roback J, Combs MR, Grossman B, Hillyer C, eds. Technical manual, 16th ed. Bethesda, MD: AABB, 2008:960-1.
95. Pisciotto PT, Snyder EL, Napychank PA, Hopfer SM. In vitro characteristics of volume-reduced platelet concentrate stored in syringes. Transfusion 1991;31:404-8.
96. Yazer MH, Podlosky L, Clarke G, Nahirniak SM. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion 2004;44:10-15.
97. Paglino JC, Pomper GJ, Fisch JS, et al. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 2004;44:16-24.
98. Vamvakas EC. Is white blood cell reduction equivalent to antibody screening in preventing transmission of cytomegalovirus by transfusion? A review of the literature and meta-analysis. Transfus Med Rev 2005;19:181-99.
99. The Trial To Reduce Alloimmunization To Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997;337:1861-9.
100. Tablin F, Oliver AE, Walker NJ, et al. Membrane phase transition of intact human platelets: Correlation with cold-induced activation. J Cell Physiol 1996;168:305-13.
101. Valeri CR, Feingold H, Marchionni LD. A simple method for freezing human platelets using 6% dimethylsulfoxide and storage at - 80°C. Blood 1974;43:131-6.
102. Schiffer CA, Aisner J, Wiernik PH. Clinical experience with transfusion of cryopreserved platelets. Br J Haematol 1976;34:377-85.
103. Towell BL, Levine SP, Knight WA, Anderson JL. A comparison of frozen and fresh platelet concentrates in the support of thrombocytopenic patients. Transfusion 1986;26:525-30.
104. Currie LM, Livesey SA, Harper JR, Connor J. Cryopreservation of single-donor platelets with a reduced dimethyl sulfoxide concentration by the addition of second-messenger effectors: Enhanced retention of in vitro functional activity. Transfusion 1998;38:160-7.
105. Currie LM, Lichtiger B, Livesey SA, et al. Enhanced circulatory parameters of human platelets cryopreserved with second- messenger effectors: An in vivo study of 16 volunteer platelet donors. Br J Haematol 1999;105:826-31.
106. Lazarus HM, Kaniecki-Green HA, Warm SE, et al. Therapeutic effectiveness of frozen platelet concentrates for transfusion. Blood 1981;57:243-9.
107. Pedrazzoli P, Noris P, Perotti C, et al. Transfusion of platelet concentrates cyropreserved with ThromboSol plus low-dose dimethyl- sulphoxide in patients with severe thrombocytopenia: A pilot study. Br J Haematol 2000;108:653-9.
108. Jackson DP, Sorenson DK, Cronkite EP, et al. Effectiveness of transfusions of fresh and lyophilized platelets in controlling bleeding due to thrombocytopenia. J Clin Invest 1959;38:1689-97.
109. Firkin BG, Arimura G, Harrington WJ. A method for evaluating the haemostatic efficacy of various agents in thrombocytopenic rats and mice. Blood 1960;15:388-94.
110. Read MS, Reddick RL, Bode AP, et al. Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: Potential for long-term storage of dried platelets for transfusion. Proc Natl Acad Sci U S A 1995:92:397-401.
111. Lee DH, Blajchman MA. Novel treatment modalities: New platelet preparations and substitutes. Br J Haematol 2001;114:496-505.
112. Tang M, Wolkers WF, Crowe JH, Tablin F. Freeze-dried rehydrated human blood platelets regulate intracellular pH. Transfusion 2006;46:1029-37.
113. Blajchman MA. Substitutes and alternatives to platelet transfusions in thrombocytopenic patients. J Thromb Haemost 2003;1:1637-41.
114. Reid TJ, Rentas FJ, Ketchum LH. Platelet substitutes in the management of thrombocytopenia. Curr Hematol Rep 2003;2:165-70.